The S1P receptor agonist etrasimod has been shown to induce remission in patient with ulcerative colitis.
Etrasimod, a medication that activates S1P receptors, has been found to be effective in inducing remission in individuals with ulcerative colitis, a type of inflammatory bowel disease.